• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 7
  3. Author

Online ISSN: 2515-8260

Volume9, Issue7

Assessment of prescribing patterns of medicines in chronic kidney disease patients

    Dr.Mohit Patnaik

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 7, Pages 4263-4267

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Chronic kidney disease (CKD) is characterized by progressive decline in glomerular filtration rate (GFR). The present study was conducted to assess prescribing patterns of medicines in chronic kidney disease (CKD) patients.
Materials & Methods: 78 patients of CKD of both genders were assessed for clinical profile, drug usage patterns, and medication-related problem. Suspected adverse drug reactions (ADRs) were recorded.
Results: Out of 78 patients, males were 30 and females were 48. Cardiovascular drugs used by patients was diuretics in 24, ACE inhibitors in 10, calcium channel blocker in 8, beta blockerin 6, gastrointestinal drugs such as H2 blockers in 12, proton pump inhibitor in 4, Hematopoietics such as iron in 2, folate in 3 and erythropoietinin 4, antibiotics such as cefoperazone          in 2, levofloxacin in 1 and ceftriaxone in 2 patients. The difference was significant (P<0.05). Adverse drug reactions observed were hyponatremia in 25%, hypokalaemia in 14% and hypoglycaemia in 8% patients. The difference was significant (P< 0.05).
Conclusion: Common administered drugs in patients with chronic kidney disease was cardiovascular drugs followed by gastrointestinal drugs, hematopoietics and antibiotics. Common adverse drug reactions observed were hyponatremia, hypokalaemia and hypoglycaemia.
Keywords:
    chronic kidney disease gastrointestinal drugs hyponatremia
  • PDF (201 K)
  • XML
(2022). Assessment of prescribing patterns of medicines in chronic kidney disease patients. European Journal of Molecular & Clinical Medicine, 9(7), 4263-4267.
Dr.Mohit Patnaik. "Assessment of prescribing patterns of medicines in chronic kidney disease patients". European Journal of Molecular & Clinical Medicine, 9, 7, 2022, 4263-4267.
(2022). 'Assessment of prescribing patterns of medicines in chronic kidney disease patients', European Journal of Molecular & Clinical Medicine, 9(7), pp. 4263-4267.
Assessment of prescribing patterns of medicines in chronic kidney disease patients. European Journal of Molecular & Clinical Medicine, 2022; 9(7): 4263-4267.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 20
  • PDF Download: 47
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus